Avenues for the Development of Therapeutics That Target Trace Amine Associated Receptor 1 (TAAR1)
2012
G protein-coupled receptors (GPCRs) play an inordinately large role in human health. They are the targets of many clinically relevant medications and are also candidate therapeutic targets under current investigation for a wide spectrum of diseases. Drugs targeting GPCRs are used as antihypertensives, anti-allergenic/asthmatics, antipsychotics, and to treat numerous other disorders across a broad spectrum of diseases. One recent study focusing on the DrugBank database found that 19% of all human drug targets are GPCRs and ~36% of all drugs currently approved for market target GPCRs.1 Accordingly, GPCRs are by far the single largest protein family for drug targets; currently, 63 of 200 drugs with the highest sales volume in the United States target GPCRs. Further, this overrepresentation of GPCRs has been steady since the early 1980s and continues to this day.1,2
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
44
References
21
Citations
NaN
KQI